Clinical Scorecard: Case Series of Corneal Epithelial Ingrowth After SMILE Offers Management Insights
At a Glance
| Category | Detail |
|---|---|
| Condition | Corneal Epithelial Ingrowth |
| Key Mechanisms | Disruptions during surgery, cell/tissue fragments, genetic predisposition, isolated areas unrelated to flap edges. |
| Target Population | Patients undergoing SMILE surgery |
| Care Setting | Ophthalmology clinics performing refractive surgery |
Key Highlights
- Incidence of epithelial ingrowth post-SMILE is around 0.02%, lower than LASIK.
- Patients presented with blurred vision and mild foreign body sensation.
- Epithelial ingrowth identified at the lenticule interface with opaque bubble layers as a contributor.
- Surgical intervention successfully removed ingrown epithelial cells with no recurrence after 12 months.
- Preventative measures include optimal suction cone positioning and postoperative corticosteroids.
Guideline-Based Recommendations
Diagnosis
- Use slit-lamp microscopy to identify epithelial ingrowth.
Management
- Surgical removal of ingrown epithelial cells through a small incision.
Monitoring & Follow-up
- Follow-up for at least 12 months to assess recurrence.
Risks
- Increased risk of infection with more invasive procedures.
Patient & Prescribing Data
Patients with corneal epithelial ingrowth post-SMILE surgery.
Topical corticosteroids and bandage contact lenses are recommended postoperatively.
Clinical Best Practices
- Ensure proper application of topical anesthesia.
- Communicate preoperatively to minimize unwanted eye movement.
- Optimize suction cone positioning and timing to reduce complications.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
